Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: February 6, 2026

  • Open
    82.11
  • High
    85.05
  • Low
    81.55
  • Close
    84.49
  • Volume
    812,792

Financial ratios

Dec 31, 2024